Pascal Touchon - 25 Jun 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
President and CEO, Director
Signature
/s/ David Tucker, Attorney-in-Fact for Pascal Touchon
Issuer symbol
ATRA
Transactions as of
25 Jun 2021
Net transactions value
-$231,660
Form type
4
Filing time
29 Jun 2021, 16:06:09 UTC
Previous filing
20 May 2021
Next filing
19 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $231,660 -14,194 -4% $16.32* 345,114 25 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted Restricted Stock Units.